- Home
- HOWL vs GRF Comparison
HOWL vs GRF Comparison
Compare HOWL & GRF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOWL
- GRF
- Stock Information
- Founded
- HOWL 2017
- GRF 1989
- Country
- HOWL United States
- GRF United States
- Employees
- HOWL N/A
- GRF N/A
- Industry
- HOWL Biotechnology: Pharmaceutical Preparations
- GRF Finance/Investors Services
- Sector
- HOWL Health Care
- GRF Finance
- Exchange
- HOWL Nasdaq
- GRF Nasdaq
- Market Cap
- HOWL 47.1M
- GRF 42.6M
- IPO Year
- HOWL 2021
- GRF N/A
- Fundamental
- Price
- HOWL $1.33
- GRF $10.52
- Analyst Decision
- HOWL Strong Buy
- GRF
- Analyst Count
- HOWL 5
- GRF 0
- Target Price
- HOWL $7.20
- GRF N/A
- AVG Volume (30 Days)
- HOWL 135.8K
- GRF 3.0K
- Earning Date
- HOWL 11-06-2025
- GRF 01-01-0001
- Dividend Yield
- HOWL N/A
- GRF 3.70%
- EPS Growth
- HOWL N/A
- GRF N/A
- EPS
- HOWL N/A
- GRF 1.16
- Revenue
- HOWL N/A
- GRF N/A
- Revenue This Year
- HOWL N/A
- GRF N/A
- Revenue Next Year
- HOWL N/A
- GRF N/A
- P/E Ratio
- HOWL N/A
- GRF $8.15
- Revenue Growth
- HOWL N/A
- GRF N/A
- 52 Week Low
- HOWL $0.60
- GRF $7.93
- 52 Week High
- HOWL $4.18
- GRF $10.19
- Technical
- Relative Strength Index (RSI)
- HOWL 52.75
- GRF 53.41
- Support Level
- HOWL $1.29
- GRF $10.50
- Resistance Level
- HOWL $1.40
- GRF $10.87
- Average True Range (ATR)
- HOWL 0.07
- GRF 0.21
- MACD
- HOWL 0.00
- GRF 0.00
- Stochastic Oscillator
- HOWL 61.90
- GRF 55.34
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.
About GRF Eagle Capital Growth Fund Inc.
Eagle Capital Growth Fund Inc is a diversified closed-end investment company. The fund's objective is long-term growth utilizing the concept of total return for selecting investments. It seeks to achieve its investment objectives by investing predominantly in U.S. issuer common stock by giving preference to high-quality companies, where high quality denotes substantial operating income margins, high returns on capital, and robust balance sheets.